Herantis Pharma to participate in Inderes Life Science evening
Herantis Pharma Plc, Press Release, 7 December 2022 at 09:00 A.M. EEST Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, today announced that CEO, Antti Vuolanto will participate and give a company presentation at: Inderes Life Science evening Date: December 13, 2022 Location: Helsinki, Finland For more information, please contact: Julie Silber/Gabriela Urquilla Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19 Email: ir@herantis.com Certified Advisor: UB Securities Ltd, Finland: +358 9 25 380 225,